Categories
Health

Thailand finance minister on vaccine rollout, tourism restoration

SINGAPORE – Thailand will receive its first batch of vaccines next month and plans to produce its own vaccines, according to finance ministers.

Initially, about 100,000 cans will arrive, Arkhom Termpittayapaisith told CNBC’s “Squawk Box Asia” on Friday.

“The first vaccines will be coming to Thailand next month, the first lot,” he said, adding that Thai company Siam Bioscience will be working with Anglo-Swedish pharmaceutical company AstraZeneca to develop vaccines that will be useful for both Thailand and other countries are available.

He spoke to CNBC as part of the coverage of the World Economic Forum’s Davos agenda.

Thailand will begin rolling out vaccines on Feb. 14 and intends to vaccinate 19 million people in the first phase, its prime minister said on Wednesday, according to a Reuters report.

The Southeast Asian nation has According to the report, 26 million cans of AstraZeneca to be made by Siam Bioscience and 2 million cans of China’s Sinovac were secured. It has also reserved 35 million cans from AstraZeneca, it added.

Pandemic meets tourism

Termpittayapaisith also said tourism is expected to recover by the end of the year rather than mid-year as forecast. The Thai economy relies heavily on tourism for its growth, but the arrivals of foreign tourists almost completely stalled during the pandemic.

Tourist arrivals fell 66% to 6.69 million in the first six months of 2020 as countries around the world imposed bans and travel restrictions due to the pandemic.

By comparison, Thailand had a record 39.8 million tourists in 2019, according to Reuters. Tourist spending represented around 11% of Thailand’s GDP that year, the report said.

Commuters wearing face masks wait for a canal boat in Bangkok on March 2, 2020.

MLADEN ANTONOV | AFP | Getty Images

“We’re also focusing on domestic consumption so you can see that the economic package … encourages more spending on the basic economy,” Termpittayapaisith said, adding that it aims to offset the decline in international tourism revenue.

Thailand lowered its forecast for economic growth for this year from 4.5% to 2.8% on Thursday. According to the central bank, the economy is expected to shrink by 6.6% in 2020.

The country reported a record 959 cases on Tuesday, the highest daily increase since early January when it accelerated its testing, according to Reuters.

Thailand has one of the lowest reported cases in Southeast Asia. So far, 17,023 cases and 76 deaths have been reported, according to the Johns Hopkins University.

Categories
Health

Voters extra optimistic about Covid, blame feds for vaccine rollout: NBC ballot

USC School of Pharmacy Assistant Professor Richard Dang (R) gives Ashley Van Dyke a Covid-19 vaccine as a mass vaccination of health care workers is happening on January 15, 2021 at Dodger Stadium in Los Angeles, California.

Irfan Khan | AFP | Getty Images

With President Joe Biden making tackling the Covid-19 crisis his top priority, American voters are a little more optimistic about the pandemic than they were last fall, according to a new poll by NBC News.

Still, many respondents are dissatisfied with the sluggish introduction of the vaccine in the country, and a majority blame the federal government, according to the survey.

Poll results released Thursday showed that 38% of registered voters believe the worst of the health crisis is behind the country, while 44% believe the worst is yet to come. In a poll conducted just before the November elections, those numbers were 25% and 55%, respectively.

In his inaugural address on Wednesday, Biden warned of a difficult battle against the impending coronavirus.

“We are entering what is possibly the toughest and deadliest phase of the virus,” he said.

The country has at least 193,600 new coronavirus cases and at least 3,030 Covid deaths every day, based on a 7-day average calculated by CNBC using data from Johns Hopkins University. New, more infectious strains of the virus have emerged in the United States. At least 406,000 Americans have died from the virus since the pandemic started early last year.

The U.S. has failed to meet its target of vaccinating 20 million people by the end of 2020. Under the administration of former President Donald Trump, just over 14.2 million people had received one or more doses of the Covid-19 vaccine on Wednesday morning, according to the CDC.

While respondents to the NBC survey expressed a slight increase in optimism about the pandemic, more than half of respondents were previously dissatisfied with the introduction of vaccines: 30% said vaccine administration went poorly, while 25% said it was bad that they “didn’t” run too well. “

Another 11% said it was handled “very” well, and 31% said it went “fairly” well.

Among those who said the rollout was below average, 64% primarily blamed the federal government, while 21% blamed the state governments. Another 11% blamed both of them the same.

The answers diverged across the party lines. 79% of Democratic voters who criticized the introduction of the vaccine blamed the federal government. Among Republicans who were dissatisfied with the distribution, 52% blamed states.

The poll polled 1,000 registered voters nationwide from January 10-13. The error rate is plus or minus 3.1 percentage points.

Biden’s plan

Biden plans to accelerate vaccine rollout by increasing funding for local and state officials, creating more vaccination sites, and launching a national awareness campaign, according to his Covid Response Plan released Thursday. Previously, Biden said his government will try to give 100 million vaccine shots in the first 100 days.

His incoming health officials have expressed dismay at the state of the federal vaccine distribution plan.

“What we inherit from the Trump administration is so much worse than we could have imagined,” Jeff Zients, Biden’s Covid Response coordinator, told reporters. “We have to vaccinate as much of the US population as possible to get out of this pandemic, but we don’t have the infrastructure.”

On his first day in office, Biden restored the national security team in charge of global health, safety and biological defense, urged authorities to extend statewide moratoriums on evictions and foreclosures, and urged the Department of Education to put a break on student loan payments and interest to extend.

The president has also issued a mask mandate for anyone visiting a federal building or state, or using certain public transportation. Biden launched a 100-Day Masking Challenge that asked Americans to wear face coverings in public for the next 100 days.

Adopting a new Covid aid package will be a challenge for the new Congress and the White House. Democrats have a small majority in both houses of Congress, and Republicans are skeptical about spending increases.

“We have to put politics aside and finally face this pandemic as a nation,” Biden said on Wednesday.

Categories
Health

NJ governor blames Walgreens, federal authorities for sluggish Covid vaccine rollout

New Jersey Governor Phil Murphy (D) blamed Walgreens and the federal government for the Garden State’s sluggish vaccine rollout during an interview Wednesday night on CNBC’s The News with Shepard Smith.

“The big reason is the federal program with CVS and Walgreens,” Murphy said. “They basically amassed these cans, they are planning visits to long-term care homes, they are extending their lives and they are suffering from their weight, especially at Walgreens, and that is where most of the remaining cans are.”

Murphy suggested to Shepard Smith that Walgreens “put more bodies on the case” to solve the rollout problem.

On Tuesday, Murphy said that New Jersey was effectively equipped to distribute the vaccine, but that all vendors were missing “are the vaccine doses.” New Jersey has a population of approximately 8,882 million people and has distributed 898,550 vaccines while only 432,220 of them have been administered, according to the Centers for Disease Control and Prevention.

Pointing out the Covid vaccine doses under state control, Murphy said they get into people’s arms more efficiently.

“There aren’t many doses in hospitals or other distribution points that we directly control that are not in use,” Murphy said. “We get shot in the arms with all areas we can control.”

Smith pushed back with Murphy, insisting that “people lose” when it comes to the slow adoption of vaccines. There are currently more than 123,000 Americans in the hospital and an average of 3,000 people die each day, according to a CNBC analysis of Johns Hopkins data. The pandemic has killed more than 400,000 people since the pandemic started early last year. Murphy pointed to the federal government.

“There is no question that we have a huge imbalance between supply and demand that, with all due respect, begins with the federal government, at least to this day, after they dropped the ball – too promising and too little delivered,” Murphy said. “So if Walgreens hits 1,000, if CVS hits 1,000, and we as a state continue to do what we do, which gets vaccines into people’s arms, we’ve still been disappointed by the Fed.”

Murphy applied for up to $ 20 billion in federal aid to help with Covid’s deficits. President Joe Biden said Friday that he would use the Defense Production Act to increase vaccine supplies during his first month in office.

Categories
Business

Richard Branson on journey restoration, rollout efforts

Sir Richard Branson told CNBC Tuesday that he hopes that potential passengers who have been vaccinated will have what are known as Covid vaccination cards available so they may bypass other virus mitigation measures before traveling.

“Vaccination is everything. Once the vulnerable in particular are vaccinated, I think all kinds of businesses can reopen: restaurants, travel companies, cruise lines,” said Branson, co-founder of Virgin Atlantic and Virgin Australia.

“Hopefully there will be a vaccination certificate that will allow people to get on a plane without being tested or quarantined,” added the British businessman in an interview with Squawk on the Street. ”

Branson’s comments come a week after the U.S. Centers for Disease Control and Prevention announced that passengers would be required to prove they recently tested negative for the coronavirus before flying into the country.

And on Monday, President-elect Joe Biden spokeswoman Jen Psaki said in a tweet that the new administration would maintain an entry ban for most visitors from Europe, the UK and Brazil. This announcement came shortly after President Donald Trump announced that he would lift travel restrictions.

Covid vaccination passports are a way for people to prove they have been vaccinated against the disease, and some believe they can help economic recovery from the pandemic. A group called the Vaccination Credential Initiative, supported by Microsoft and Oracle, was recently launched. The coalition is working to develop a way that people can get an encrypted digital version of vaccination logs that can then be stored in a digital wallet of their choice such as the Apple Wallet or Google Pay.

“As the world begins to recover from the pandemic, electronic access to vaccinations, tests, and other medical records will be critical to resumption of travel and more,” said Mike Sicilia, executive vice president of Oracle’s global business units , in a press release about the initiative.

Airlines and the travel industry have been hard hit by the coronavirus pandemic. Industry executives have pointed out time and again that widespread Covid vaccinations are key to robust recovery.

While air travel isn’t at the bottom of the pandemic, Branson expects it will spike in the coming months as vaccinations continue to roll out. He praised efforts across the UK to get vaccinations, as well as Biden’s promise to vaccinate 100 million Americans in 100 days.

“I would hope that in three or four months, once most of the vulnerable are vaccinated, we can look forward to late spring or summer to get back to normal,” said Branson.

Categories
Health

Senate Democrats demand Trump repair ‘failed’ rollout

A CVS pharmacist will deliver the Pfizer / BioNTech COVID-19 vaccine to a resident at Emerald Court senior community in Anaheim, CA, Friday, January 8, 2021.

Paul Bersebach | MediaNews Group | Orange County Register via Getty Images

Senate Democrats on Monday asked the Trump administration to make changes to its strategy for introducing Covid-19 vaccines. They said they “failed” states by failing to provide detailed guidance on how to effectively distribute potentially life-saving doses to Americans across the country.

The US “cannot afford to have this vaccination campaign continue to be hampered by the lack of planning, communication and leadership we have seen so far,” Senate minority chairman Chuck Schumer and 44 other Democrats said in a letter to the minister for health and human services, Alex Azar dated Monday. “The metric that matters, and where we are clearly moving too slowly, is vaccines in weapons.”

“A vaccine that is listed on a table, or even a vaccine that is distributed and sitting on one self, is not enough to protect someone,” added the legislature.

HHS did not immediately respond to CNBC’s request for comment.

Trump administration officials have confirmed vaccine distribution has been slower than hoped, citing recent holidays as a possible factor. As of Monday morning, more than 25.4 million doses of vaccine had been distributed in the US, but just over 8.9 million vaccinations had been given, according to the Centers for Disease Control and Prevention. The number is a far cry from the federal government’s goal of vaccinating 20 million Americans by the end of 2020 and 50 million Americans by the end of this month.

State and local health officials have said they are strapped for cash. They blame inadequate funding and inconsistent communications from the federal government for slowing down the number of doses being administered.

The American Hospital Association urges Azar to give more federal support and coordination to the distribution of Covid-19 vaccines. The slow rollout has raised questions about how quickly the public can be vaccinated.

Additionally, President-elect Joe Biden, due to be inaugurated in less than two weeks, criticized the introduction of the vaccine, currently saying, “It will be years, not months, for the American people to be vaccinated.”

US officials expect vaccinations to accelerate in the coming weeks. In an attempt to speed up the pace of vaccinations, the Commissioner of Azar and the Food and Drug Administration, Dr. Stephen Hahn, last week urged states to start vaccinating lower priority groups against Covid-19. The CDC recommends giving priority to healthcare workers and nursing homes first, but states are free to distribute the vaccine at their discretion.

Hahn told reporters that states should give shots to groups that “make sense” such as the elderly, people with pre-existing conditions, police, fire departments and other key workers.

“We heard in the press that some people said, ‘OK, I’m waiting for all of my healthcare workers to be vaccinated. We have a vaccine intake of around 35%.’ I think it makes sense to expand this to other groups, Hahn said on Friday at an event organized by the Alliance for Health Policy. “I would strongly encourage states to be more expansive about who they can give the vaccine to.”

Democrats said the Trump administration should issue a “Comprehensive National Plan” that would include guidelines on vaccine delivery and assisting states with supplies and manpower to manage gunshots.

“In the absence of this long-overdue national plan, it is even more important that the Trump administration actively engage in state planning efforts in the coming days, identify sales and administrative challenges, and proactively address issues that arise in partnership with jurisdictions,” he wrote Legislator.

Categories
Business

Rollout may dent Macron’s re-election probabilities

French President Emmanuel Macron.

LOIC VENANCE | AFP | Getty Images

LONDON – France is currently lagging far behind other European countries with its introduction of Covid-19 vaccines, potentially affecting President Emmanuel Macron’s chances of re-election.

By Friday, 80,000 French citizens had been vaccinated against the corona virus. In comparison, neighboring Germany has carried out hundreds of thousands of vaccinations.

Success or failure in vaccinating the population is likely to shape the political debate as the campaign for the 2022 presidential race intensifies in the coming months.

“Although the 2022 presidential election seems a long way off, President Macron is certainly concerned that a poorly implemented vaccine roll-out could affect his chances for another term,” Jessica Hinds, a European economist with Capital Economics, told CNBC on Thursday .

Macron was neck to neck with far-right leader Marine Le Pen in an opinion poll published in October.

The French president has reportedly complained that the pace of vaccinations is “not worthy of the moment or the French people” and said the situation needs to change “quickly and in particular,” Le Journal du Dimanche reported earlier this month. The president’s office was not immediately available for comment when CNBC contacted him on Monday.

“A slow rate of vaccination would limit the government’s ability to lift restrictions that weigh on the economy and people’s daily lives. This would be clearly unpopular among (French) voters, especially if other countries like Germany are able to remove them sooner “said Hinds.

Bureaucracy was the main reason for the delays. Citizens had to seek advice and consent from their doctor before vaccination before vaccination.

“What I notice about the French strategy is that officials haven’t paid much attention to logistics,” Jeremy Ghez, a professor at HEC Paris Business School, told CNBC via email.

Reports from the country also suggest that the population has a high anti-vaccine sentiment compared to other countries.

French Health Minister Olivier Veran initially suggested that careful distribution should take into account concerns about the vaccine among the population. An Ipsos poll published in late December found that only 40% of French people had plans to get the coronavirus vaccine.

But the French government now wants to reverse the situation by simplifying the process. France’s Veran said that people aged 75 and over can make an appointment online or by phone to get vaccinated.

The country is also expanding the eligibility criteria and the government has vowed that 1 million people will be vaccinated before the end of the month.

France was one of the nations hardest hit by the pandemic. Prime Minister Jean Castex said Thursday that restaurants and ski resorts will be closed at least until mid-February and the night curfew will be extended until the end of January.

The social restrictions weigh on the economy. French GDP is likely to have contracted by more than 9% in 2020.

The slower the vaccine adoption, the longer parts of the economy will remain closed.

“The French economy is under anesthesia and only when you pull the plug will you really know how quickly economic players can recover. If this happens quickly, I like Macron’s chances because there are so few alternatives to this day. If not “I would argue that all bets are void,” said Ghez of how economic performance will affect the presidential election.

Macron defeated Le Pen in 2017 on a pro-EU agenda.

Categories
Health

‘It Turned Kind of Lawless’: Florida Vaccine Rollout Turns Right into a Free-for-All

MIAMI — Linda Kleindienst Bruns registered for a coronavirus vaccine in late December, on the first day the health department in Tallahassee, Fla., opened for applications for people her age. Despite being 72, with her immune system suppressed by medication that keeps her breast cancer in remission, she spent days waiting to hear back about an appointment.

“It’s so disorganized,” she said. “I was hoping the system would be set up so there would be some sort of logic to it.”

Phyllis Humphreys, 76, waited with her husband last week in a line of cars in Clermont, west of Orlando, that spilled onto Highway 27. They had scrambled into their car and driven 22 miles after receiving an automated text message saying vaccine doses were available. But by 9:43 a.m., the site had reached capacity and the Humphreys went home with no shots.

“We’re talking about vaccinations,” said Ms. Humphreys, a retired critical care nurse. “We are not talking about putting people in Desert Storm.”

Florida is in an alarming new upward spiral, with nearly 20,000 cases of the virus reported on Friday and more than 15,000 on Saturday. But the state’s well-intended effort to throw open the doors of the vaccine program to everyone 65 and older has led to long lines, confusion and disappointment.

States across the country, even as they race to finish vaccinating health care employees, nursing home residents and emergency workers, are under pressure from residents to reach a broader section of the public. Florida, which has already prioritized a large swath of its population to receive the vaccine, illustrates the challenges of expanding a vaccination program being developed at record speed and with limited federal assistance.

“How do you do something this huge and roll it out?” said Dr. Leslie M. Beitsch, the chairman of the behavioral sciences and social medicine department at Florida State University. “It’s not in any way surprising — to anyone who followed it closely, for sure — that there would be halting kind of progress and missteps getting something of this magnitude underway initially, whether we’re talking about Florida or the entire country.”

Guidelines from the Centers for Disease Control and Prevention recommend giving the next priority after the earliest groups to essential workers and people 75 and older. Some states, including Florida, Texas, Oklahoma and Hawaii, decided to vaccinate people 65 and older, even before essential workers, and other states are following suit.

But with states and counties left to largely sort out logistics by themselves, the rollout has gone anything but smoothly.

People camped out overnight in the Florida winter chill in Fort Myers and Daytona Beach for vaccines administered on a first-come-first-served basis, a spectacle that made national headlines. Health department offices in Sarasota and several other counties, unequipped to schedule vaccine appointments on their own websites, resorted to using Eventbrite, a service usually associated with invitations to dinner parties and art exhibitions.

Palm Beach County was accepting vaccine requests only by email, said the county’s health administrator, Dr. Alina Alonso, after the county’s phone system “absolutely died.” People in the queue were warned that they might have to wait months for an appointment. In the meantime, some wealthy people with connections to health care facilities have been able to get the vaccine more easily.

Adding to the complications, the Florida Division of Emergency Management announced on Sunday that its coronavirus testing and vaccination site at Hard Rock Stadium in Miami Gardens — the recent scene of long lines of people awaiting vaccination — would be shut down for much of Monday to make way for the College Football Playoff national championship game.

Experts say Florida is an example of what happens when officials attempt to distribute a vaccine that is still in very limited supply to a broad spectrum of the population. In a state with about 4.4 million people 65 and older, more than 402,000 doses had been administered as of Friday, according to federal data, the fourth-highest total in the nation. But Florida has used only about 30 percent of the vaccine doses it has received, behind 29 other states.

Some people have been successful, including Janice and Walter Greer, who were in the same line as the Humphreys in Clermont on Wednesday. Ms. Greer had called Lake County repeatedly, hoping to get information about vaccine availability.

Mr. Greer has a brother in Ohio with Covid-19. “I couldn’t go and see him,” he said softly, welling up with tears. “He has pneumonia.”

But while the Greers got in line early enough to receive shots, many more people left without one and were quite upset.

“My heart is beating 100 miles a minute,” said Shirley LaBoy, 65, of Polk County, who got to the recreation center only to see a line of cars and a digital road sign saying “NO VACCINES TODAY.”

Covid-19 Vaccines ›

Answers to Your Vaccine Questions

If I live in the U.S., when can I get the vaccine?

While the exact order of vaccine recipients may vary by state, most will likely put medical workers and residents of long-term care facilities first. If you want to understand how this decision is getting made, this article will help.

When can I return to normal life after being vaccinated?

Life will return to normal only when society as a whole gains enough protection against the coronavirus. Once countries authorize a vaccine, they’ll only be able to vaccinate a few percent of their citizens at most in the first couple months. The unvaccinated majority will still remain vulnerable to getting infected. A growing number of coronavirus vaccines are showing robust protection against becoming sick. But it’s also possible for people to spread the virus without even knowing they’re infected because they experience only mild symptoms or none at all. Scientists don’t yet know if the vaccines also block the transmission of the coronavirus. So for the time being, even vaccinated people will need to wear masks, avoid indoor crowds, and so on. Once enough people get vaccinated, it will become very difficult for the coronavirus to find vulnerable people to infect. Depending on how quickly we as a society achieve that goal, life might start approaching something like normal by the fall 2021.

If I’ve been vaccinated, do I still need to wear a mask?

Yes, but not forever. The two vaccines that will potentially get authorized this month clearly protect people from getting sick with Covid-19. But the clinical trials that delivered these results were not designed to determine whether vaccinated people could still spread the coronavirus without developing symptoms. That remains a possibility. We know that people who are naturally infected by the coronavirus can spread it while they’re not experiencing any cough or other symptoms. Researchers will be intensely studying this question as the vaccines roll out. In the meantime, even vaccinated people will need to think of themselves as possible spreaders.

Will it hurt? What are the side effects?

The Pfizer and BioNTech vaccine is delivered as a shot in the arm, like other typical vaccines. The injection won’t be any different from ones you’ve gotten before. Tens of thousands of people have already received the vaccines, and none of them have reported any serious health problems. But some of them have felt short-lived discomfort, including aches and flu-like symptoms that typically last a day. It’s possible that people may need to plan to take a day off work or school after the second shot. While these experiences aren’t pleasant, they are a good sign: they are the result of your own immune system encountering the vaccine and mounting a potent response that will provide long-lasting immunity.

Will mRNA vaccines change my genes?

No. The vaccines from Moderna and Pfizer use a genetic molecule to prime the immune system. That molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse to a cell, allowing the molecule to slip in. The cell uses the mRNA to make proteins from the coronavirus, which can stimulate the immune system. At any moment, each of our cells may contain hundreds of thousands of mRNA molecules, which they produce in order to make proteins of their own. Once those proteins are made, our cells then shred the mRNA with special enzymes. The mRNA molecules our cells make can only survive a matter of minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a bit longer, so that the cells can make extra virus proteins and prompt a stronger immune response. But the mRNA can only last for a few days at most before they are destroyed.

“I found myself on the computer all day. I feel, emotionally, all stressed out,” said Ms. LaBoy, who has been unable to see her children for fear of contracting the virus. “We are tired of being locked in. Then I get an opportunity to get the vaccine, and I can’t even get that.”

Aaron Kissler, the health administrator for Lake County, said officials wanted to get shots in arms quickly, even without a more organized appointment system available. “Right now, we just wanted to get out as much as possible,” he said.

In Texas, about 527,000 residents had received at least the first vaccine dose as of Friday, according to the Texas Department of State Health Services. About 107,000 of them were 65 or older, out of more than 3.7 million Texans eligible in that age range. But there have been problems similar to Florida’s.

Dr. Bob Kelly, a 77-year-old retired veterinarian in Austin, said he made 20 or more phone calls searching for a vaccine before he finally connected one night at 3 a.m. on a hospital internet link that offered an appointment for several days later.

He and his wife drove 25 miles to the appointment, only to be told that supplies were so limited that the vaccine would only be given to people with aggravating health conditions. So they are back to where they started, with their names on five waiting lists at pharmacies, chain hospitals and a doctor’s office.

“That’s what’s going on,” Dr. Kelly said. “The rollout is slow, the method of administration is not efficient and who gets it is kind of arbitrary.”

In Florida, Gov. Ron DeSantis, a Republican, has acknowledged that the initial rollout has been bumpy.

But he has steadfastly defended the state’s decision to open the door to all seniors, saying he could not in good conscience see a 20-something who bags groceries getting vaccinated before a grandparent, not in a state where of the more than 22,000 people killed by the coronavirus, 83 percent have been 65 or older.

The plurality of vaccine doses have gone so far to people between the ages of 65 and 74, not to people 75 and older who are the most vulnerable to the virus.

Some of the lag in numbers may be a result of older people who are being extra cautious about getting a new vaccine developed in record time. But older seniors may also be at a disadvantage because the process has often required a degree of computer proficiency and has generally not been clear or consistent, Dr. Beitsch said.

“Each of our 67 counties seems to be taking a slightly different pathway — and that’s remarkable, because we have a single department of health that is supposed to cover the entire state,” said Dr. Beitsch, whose 71-year-old tech-savvy brother got vaccinated in Orlando after filling out a request form that took him about 40 minutes.

The Florida Department of Health is working on an online appointment system for all counties, but it is not yet ready, though the DeSantis administration says it has been preparing for the vaccine rollout since July. It stockpiled millions of supplies and enrolled more than 270 providers to receive the shots once they became available.

Mr. DeSantis said his administration moved more aggressively than other states, getting teams of health workers and National Guard members to nursing homes the week before CVS and Walgreens pharmacies began vaccinating those residents. Florida is also distributing doses to Publix supermarkets and churches to increase community access.

“We’re going to be there for our parents,” he said in a news conference on Sunday. “We’re going to be there for our grandparents. And that will do more than anything else we can do to reduce mortality and change the scope of how this virus behaves in the state of Florida.”

The lucky vaccine recipients have been thrilled.

“Everything was great,” Susan Hacker said after getting her shot on Thursday at the Century Village retirement community in Boca Raton.

The state has no residency requirement for people to get the vaccine in their home county — or to be Florida residents at all. News reports in Argentina have recounted how wealthy people vacationing in Miami managed to get vaccinations.

More worrying to officials have been private institutions distributing the vaccine to people who are not in any of the priority groups. MorseLife Health System, a nursing home and assisted living facility in West Palm Beach, is under investigation by the Florida inspector general and the health department after The New York Post and The Washington Post reported that it steered vaccines to rich donors.

In an interview on Tuesday, Hong Chae, the organization’s chief financial officer, said that a number of the nursing home’s board members and volunteers were offered the vaccine in case facility managers became incapacitated by the virus and board members needed “to come in and chip in,” he said.

Some hospitals in Miami have vaccinated board members as well, according to local doctors and patients.

One of them, Rosario Rico Toro, posted news of receiving the Pfizer vaccine to Facebook friends on Dec. 30. “Baptist vaccination day!!” she wrote alongside an image of her Covid-19 vaccination record.

In an interview, Ms. Rico Toro, a onetime Miss Bolivia who now does charitable work for hospitals, said she had received the vaccine as a result of her donations and volunteer work for Baptist Hospital in Miami. When one of the hospital’s doctors canceled an appointment to get the shot, the hospital offered her the spot.

“They called and said, ‘As a board member, would you like to get it?’” she recalled.

The hospital did not respond to requests for comment.

Ms. Rico Toro, who is 49 and in good health, said she initially hesitated. But the hospital gave her the impression that if she turned down the vaccine, it would be offered to another board member or possibly not even be used, so she took it. “My question is, why not?”

Dr. Perri Young, an internist in Miami, said that the distribution process has been shambolic and ineffective. Even as a doctor, she said, her access to information is minimal.

“It’s crazy here,” she said. “It became sort of lawless.”

By the end of week, Ms. Kleindienst Bruns in Tallahassee had gotten some good news: Her internist had received vaccine doses. Would she like one?

She got it on Saturday. “It was so easy,” she said.

Patricia Mazzei reported from Miami, Eric Adelson from Clermont, Fla., and Kate Kelly from New York. David Montgomery contributed reporting from Austin, Texas; Neil Reisner from Coconut Creek, Fla., and Boca Raton, Fla.; and Rachel Abrams from Los Angeles.

Categories
Business

Israel’s Covid vaccine rollout is the quickest on the earth

A health care worker administers a Covid-19 vaccine at Clalit Health Services in the ultra-Orthodox Israeli city of Bnei Brak on January 6, 2021.

JACK GUEZ | AFP | Getty Images

As the US, UK and Europe try to speed up their own Covid vaccination campaigns, one country is surpassing them all: Israel.

Israel’s vaccination campaign began on December 19 with Prime Minister Benjamin Netanyahu, the first person to be vaccinated in the country. Priority will be given to people over 60, healthcare workers and all clinically vulnerable people – reportedly making up around a quarter of the 9 million population.

It is ahead of other countries that have also started introducing vaccinations. To date, experts have said that around 1.5 million people in Israel received their first vaccine shot as a new lockdown came amid an increase in coronavirus cases.

According to Dr. Boaz Lev, chairman of the Disease Control and Coronavirus Vaccines Advisory Committee, has now vaccinated around 60% of the priority groups for the vaccine, although some of them are difficult to reach, such as those who only live at home by Israel’s Ministry of Health. The country is vaccinating around 150,000 people daily, he added, and intends to have vaccinated most of the country by April.

“The main goal of our vaccination program is to vaccinate as many people as possible as quickly as possible,” said Lev.

Lessons for the rest of the world

From logistics to public information campaigns, there are a number of lessons other countries could learn from trying to speed up their own vaccination campaigns.

“First of all … plan ahead. Be prepared, run a big information campaign and gain people’s trust, that’s on one side,” Lev told CNBC on Wednesday.

“Then you create a good flow of vaccines, a good flow of people … with a good administrative background so you can register them and let them know when to come for their next push. So there are a lot of things that which is basically about planning ahead and rolling it out to make it flow. “

In this aerial photo, taken in Tel Aviv, Israel, on Monday January 4, 2020, people are queuing outside a Covid-19 mass vaccination center in Rabin Sqaure. Israel plans to vaccinate 70% to 80% of its population by April or May. Health Minister Yuli Edelstein has said.

Bloomberg | Bloomberg | Getty Images

Israeli officials weren’t sure how many vaccinations the country ordered, but vaccine manufacturers reported that they received 8 million doses of the Pfizer / BioNTech vaccine and 6 million doses of the Moderna vaccine (the first batch of which was due to it) Arrival Thursday). It was not disclosed how much Oxford University / AstraZeneca vaccine the country ordered.

All of these vaccines require that each have two doses; There are reports that Israel paid higher vaccine prices than it competed to supply larger countries.

Lev said Israel’s ambitious goal of vaccinating the majority of its population through its public hospitals and vaccination centers requires careful planning. “We have to set up the logistics for this, and that takes a huge effort,” he said.

“The next is to be in the correct order in vaccinating people. Unless we have an abundance of vaccines … we need to have a very orderly queue so we know who is being vaccinated, and that should be loud some Principles, “he added. “It should be safe, it should be flexible, it should be as simple as possible, but it should also follow the principle that those who are more vulnerable should get it first … to avoid mortality and morbidity (of the pandemic) . “

Logistics and sales

Public health experts told CNBC that there were a number of factors that made it possible for Israel to vaccinate so efficiently, including the small population and geography and the efficiency of its health system.

Israel has a public health system in which everyone has to belong to one of four health organizations (HMOs) that work a bit like the UK’s National Health Service. Vaccine supplies were distributed to these HMOs, who in turn distributed them to their respective members.

Ronit Calderon-Margalit, professor of epidemiology at Hadassah-Hebrew University’s Braun School of Public Health, told CNBC on Wednesday that the vaccination campaign exceeded their expectations. “It’s amazing, it’s way beyond my wildest dreams and I don’t get to say that often,” she said.

People will receive a dose of the Pfizer-BioNTech Covid-19 vaccine at a Covid-19 mass vaccination center on Rabin Square in Tel Aviv, Israel on Monday January 4, 2020.

Bloomberg | Bloomberg | Getty Images

She attributed part of this success to the efficiency of the four HMOs: Clalit, Maccabi, Meuhedet and Leumit or “Kupot Cholim” as they are collectively known.

“They all have vaccines from the government to vaccinate the population, and they are very good at the logistics of distributing services that vaccines,” she said. Experts told CNBC that at the end of the day, hospitals and clinics are also giving the vaccines to people outside of the priority groups so as not to waste supplies.

The Israeli health system is heavily digitized, so anyone who receives the vaccine is registered as such by the Ministry of Health.

Israel recorded 466,916 cases of the virus and 3,527 deaths as of Thursday, according to Johns Hopkins University. As in other countries, there has been an increase in infections over the winter.

On Wednesday, Netanyahu blamed a new, more transmissible strain of virus, first identified in the UK (what he called the “British mutation”), responsible for an increase in cases in the country. Due to the wave of infections, Israel will enter a new strict lockdown for two weeks on Thursday at midnight.

In addition to vaccination centers and clinics, hospitals are of course at the forefront.

Yoel Har-Even is Director of International and Resource Development at Sheba Medical Center, the largest hospital in the Middle East (and by the way, where Netanyahu was vaccinated in December).

He told CNBC on Wednesday that his hospital had vaccinated around 45,000 people in the past two weeks.

These people range from the most at risk, including police officers and Holocaust survivors, an experience that Har-Even said was very moving, to teachers. He said everyone he met was happy to have received the vaccine (sentiment against vaccines is low in Israel) and the mainstream media of all political lines supported the vaccination campaign.

“We understand that this is a crucial time and everyone here agrees,” said Har-Even. “It reminds us a little of a time of war in Israel and when there is war there is unity.”

He added that people’s acceptance and willingness to receive the vaccine is a cause for great pride.

“You just have to see the lines and the queues of people standing still, there is no pushing or screaming,” he said. “The time of the corona means (the vaccination campaign) that it runs faster, quieter and with much, much more order and efficiency in the process.”

Categories
Health

Windfall Hospital System defies America’s gradual vaccine rollout development

Covid vaccination efforts in the US are well below original estimates. More than 15.4 million doses have been given to states, but only 4.5 million Americans have received their first shot, according to the Centers for Disease Control and Prevention.

However, the Providence Hospital System has bucked the country’s slow roll-out trend, providing the first dose of the vaccine to more than half of its 120,000 employees in 51 hospitals in seven states.

Dr. Amy Compton-Phillips, clinical director of Providence, told The News with Shepard Smith that “planning is the antidote to panic.” She said Providence began developing strategies in September to identify caregivers at greatest risk and incorporate technology such as email and text to streamline the rollout process.

She told Shepard Smith that one of the solutions is to create a “validation and verification” tool to manage vaccine rollouts in the vendor’s hospitals. The tool included the “roles” that consisted of specific jobs, and it also included places of work for those within the Providence system. People would then in turn reach and validate the data.

“By doing this, we avoided much of the dismay you’ve heard from other organizations that, despite their best intentions, accidentally left out important groups of people who should be vaccinated,” said Compton-Phillips. “I think the biggest lesson we’d have is not to hesitate to do something. Some vaccinations are better than none. Ask your people too, make sure you hear from them, not just them Trust data. “

Minister of Health and Human Services Alex Azar estimated that 20 million Americans could be “vaccinated” by the end of December and another 50 million could be “vaccinated” by the end of January. He added that “we expect” a total of 100 million vaccinations by the end of February.

CDC officials have attributed the slow rollout to complex vaccination stores, overburdened public health departments and health care providers, and the timing of the vaccination rollout during the holidays.

Federal officials have required states to run vaccination campaigns. On Monday, New York Governor Andrew Cuomo admitted that hospitals in his state need to give vaccines faster and threatened with fines.

“Any vendor who does not use the vaccine could be fined up to $ 100,000 in the future. They must use the allocation within seven days. Otherwise, they can be removed from future distribution,” said Cuomo.

Florida Governor Ron DeSantis issued a similar warning to hospitals, saying the state could try converting test sites into vaccination centers. California Governor Gavin Newsom has pledged US $ 300 million for vaccination measures in his current budget proposal.

Providence’s successful rollout still identified areas that needed improvement. According to the Los Angeles Times, one in five frontline nurses at the Providence Holy Cross Medical Center in Mission Hills, Calif., Turned down the shot.

Compton-Phillips noted that the hospital is in an area that is underserved and caters to a large immigrant community. She said that Providence seeks to understand the barriers to vaccination in order to better serve the community.

“We know vaccines are hesitant, especially in certain underserved communities, color communities that have less confidence in the health system. So we’re working very closely with them to understand these concerns and make sure we address them.” them so we can really convince people to do what is in their best interests and protect themselves from this virus, “said Compton-Phillips.

Categories
World News

As Rollout Falters, Scientists Debate New Vaccination Techniques

As governments around the world rush to vaccinate their citizens against the surging coronavirus, scientists are locked in a heated debate over a surprising question: Is it wisest to hold back the second doses everyone will need, or to give as many people as possible an inoculation now — and push back the second doses until later?

Since even the first shot appears to provide some protection against Covid-19, some experts believe that the shortest route to containing the virus is to disseminate the initial injections as widely as possible now.

Officials in Britain have already elected to delay second doses of vaccines made by the pharmaceutical companies AstraZeneca and Pfizer as a way of more widely distributing the partial protection afforded by a single shot.

Health officials in the United States have been adamantly opposed to the idea. “I would not be in favor of that,” Dr. Anthony S. Fauci, the nation’s top infectious disease expert, told CNN on Friday. “We’re going to keep doing what we’re doing.”

But on Sunday, Moncef Slaoui, scientific adviser of Operation Warp Speed, the federal effort to accelerate vaccine development and distribution, offered up an intriguing alternative: giving some Americans two half-doses of the Moderna vaccine, a way to possibly milk more immunity from the nation’s limited vaccine supply.

The rising debate reflects nationwide frustration that so few Americans have gotten the first doses — far below the number the administration had hoped would be inoculated by the end of 2020. But the controversy itself carries risks in a country where health measures have been politicized and many remain hesitant to take the vaccine.

“Even the appearance of tinkering has negatives, in terms of people having trust in the process,” said Natalie Dean, a biostatistician at the University of Florida.

The public rollout remained bumpy over the weekend. Seniors lined up early for vaccinations in one Tennessee town, but the doses were gone by 10 a.m. In Houston, the Health Department phone system crashed on Saturday, the first day officials opened a free vaccination clinic to the public.

Nursing home workers in Ohio were opting out of the vaccination in great numbers, according to Gov. Mike DeWine, while Mayor Eric Garcetti of Los Angeles, now a center of the pandemic, warned that vaccine distribution was moving far too slowly. Hospitalizations of Covid-19 patients during the past month have more than doubled in California.

The vaccines authorized so far in the United States are produced by Pfizer-BioNTech and Moderna. Britain has greenlit the Pfizer-BioNTech and Oxford-AstraZeneca vaccines.

All of them are intended to be delivered in multiple doses on a strict schedule, relying on a tiered protection strategy. The first injection teaches the immune system to recognize a new pathogen by showing it a harmless version of some of the virus’s most salient features.

After the body has had time to study up on this material, as it were, a second shot presents these features again, helping immune cells commit the lesson to memory. These subsequent doses are intended to increase the potency and durability of immunity.

Clinical trials run by Pfizer-BioNTech and Moderna showed the vaccines were highly effective at preventing cases of Covid-19 when delivered in two doses separated by three or four weeks.

Some protection appears to kick in after the first shot of vaccine, although it’s unclear how quickly it might wane. Still, some experts now argue that spreading vaccines more thinly across a population by concentrating on first doses might save more lives than making sure half as many individuals receive both doses on schedule.

That would be a remarkable departure from the original plan. Since the vaccine rollout began last month in the United States, second shots of the vaccines have been held back to guarantee that they will be available on schedule for people who have already gotten their first injections.

But in Britain, doctors have been told to postpone appointments for second doses that had been scheduled for January, so that those doses can be given instead as first shots to other patients. Officials are now pushing the second doses of both the Pfizer-BioNTech and Oxford-AstraZeneca vaccines as far back as 12 weeks after the first one.

In a regulatory document, British health officials said that AstraZeneca’s vaccine was 73 percent effective in clinical trial participants three weeks after the first dose was given and before the second dose was administered. (In cases in which participants never received a second dose, the interval ended 12 weeks after the first dose was given.)

But some researchers fear the delayed-dose approach could prove disastrous, particularly in the United States, where vaccine rollouts are already stymied by logistical hurdles and a patchwork approach to prioritizing who gets the first jabs.

“We have an issue with distribution, not the number of doses,” said Saad Omer, a vaccine expert at Yale University. “Doubling the number of doses doesn’t double your capacity to give doses.”

Federal health officials said last week that some 14 million doses of the Pfizer-BioNTech and Moderna vaccines had been shipped out across the country. But as of Saturday morning, just 4.2 million people in the United States had gotten their first shots.

That number is most likely an underestimate because of lags in reporting. Still, the figure falls far short of the goal that federal health officials set as recently as last month to give 20 million people their first shots by the end of 2020.

Covid-19 Vaccines ›

Answers to Your Vaccine Questions

With distribution of a coronavirus vaccine beginning in the U.S., here are answers to some questions you may be wondering about:

    • If I live in the U.S., when can I get the vaccine? While the exact order of vaccine recipients may vary by state, most will likely put medical workers and residents of long-term care facilities first. If you want to understand how this decision is getting made, this article will help.
    • When can I return to normal life after being vaccinated? Life will return to normal only when society as a whole gains enough protection against the coronavirus. Once countries authorize a vaccine, they’ll only be able to vaccinate a few percent of their citizens at most in the first couple months. The unvaccinated majority will still remain vulnerable to getting infected. A growing number of coronavirus vaccines are showing robust protection against becoming sick. But it’s also possible for people to spread the virus without even knowing they’re infected because they experience only mild symptoms or none at all. Scientists don’t yet know if the vaccines also block the transmission of the coronavirus. So for the time being, even vaccinated people will need to wear masks, avoid indoor crowds, and so on. Once enough people get vaccinated, it will become very difficult for the coronavirus to find vulnerable people to infect. Depending on how quickly we as a society achieve that goal, life might start approaching something like normal by the fall 2021.
    • If I’ve been vaccinated, do I still need to wear a mask? Yes, but not forever. Here’s why. The coronavirus vaccines are injected deep into the muscles and stimulate the immune system to produce antibodies. This appears to be enough protection to keep the vaccinated person from getting ill. But what’s not clear is whether it’s possible for the virus to bloom in the nose — and be sneezed or breathed out to infect others — even as antibodies elsewhere in the body have mobilized to prevent the vaccinated person from getting sick. The vaccine clinical trials were designed to determine whether vaccinated people are protected from illness — not to find out whether they could still spread the coronavirus. Based on studies of flu vaccine and even patients infected with Covid-19, researchers have reason to be hopeful that vaccinated people won’t spread the virus, but more research is needed. In the meantime, everyone — even vaccinated people — will need to think of themselves as possible silent spreaders and keep wearing a mask. Read more here.
    • Will it hurt? What are the side effects? The Pfizer and BioNTech vaccine is delivered as a shot in the arm, like other typical vaccines. The injection into your arm won’t feel different than any other vaccine, but the rate of short-lived side effects does appear higher than a flu shot. Tens of thousands of people have already received the vaccines, and none of them have reported any serious health problems. The side effects, which can resemble the symptoms of Covid-19, last about a day and appear more likely after the second dose. Early reports from vaccine trials suggest some people might need to take a day off from work because they feel lousy after receiving the second dose. In the Pfizer study, about half developed fatigue. Other side effects occurred in at least 25 to 33 percent of patients, sometimes more, including headaches, chills and muscle pain. While these experiences aren’t pleasant, they are a good sign that your own immune system is mounting a potent response to the vaccine that will provide long-lasting immunity.
    • Will mRNA vaccines change my genes? No. The vaccines from Moderna and Pfizer use a genetic molecule to prime the immune system. That molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse to a cell, allowing the molecule to slip in. The cell uses the mRNA to make proteins from the coronavirus, which can stimulate the immune system. At any moment, each of our cells may contain hundreds of thousands of mRNA molecules, which they produce in order to make proteins of their own. Once those proteins are made, our cells then shred the mRNA with special enzymes. The mRNA molecules our cells make can only survive a matter of minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a bit longer, so that the cells can make extra virus proteins and prompt a stronger immune response. But the mRNA can only last for a few days at most before they are destroyed.

Many of these rollout woes are caused by logistical issues — against the backdrop of a strained health care system and skepticism around vaccines. Freeing up more doses for first injections won’t solve problems like those, some researchers argue.

Shweta Bansal, a mathematical biologist at Georgetown University, and others also raised concerns about the social and psychological impacts of delaying second doses.

“The longer the duration between doses, the more likely people are to forget to come back,” she said. “Or people may not remember which vaccine that they got, and we don’t know what a mix and match might do.”

In an emailed statement, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the Food and Drug Administration, endorsed only the strictly scheduled two-dose regimens that were tested in clinical trials of the vaccines.

The “depth or duration of protection after a single dose of vaccine,” he said, can’t be determined from the research published so far. “Though it is quite a reasonable question to study a single-dose regimen in future clinical trials, we simply don’t currently have these data.”

The vaccine makers themselves have taken divergent positions.

In a trial of the Oxford-AstraZeneca vaccine, volunteers in Britain were originally intended to receive two doses given four weeks apart. But some vaccinated participants ended up receiving their doses several months apart, and still acquired some protection against Covid-19.

An extended gap between doses “gives you a lot of flexibility for how you administer your vaccines, dependent on the supply that you have,” said Menelas Pangalos, executive vice president of biopharmaceuticals research and development at AstraZeneca.

Delayed dosing could help get countries “in very good shape for immunizing large swaths of their populations to protect them quickly.”

Steven Danehy, a spokesman for Pfizer, struck a far more conservative tone. “Although partial protection from the vaccine appears to begin as early as 12 days after the first dose, two doses of the vaccine are required to provide the maximum protection against the disease, a vaccine efficacy of 95 percent,” he said.

“There are no data to demonstrate that protection after the first dose is sustained after 21 days,” he added.

Ray Jordan, a spokesman for Moderna, said the company could not comment on altering dosing plans at this time.

There is no dispute that second doses should be administered sometime near the first dose. “They key is to expose the immune system at a time when it still recognizes” the immunity-stimulating ingredients in the vaccine, said Angela Rasmussen, a virologist affiliated with Georgetown University.

During a public health emergency, “companies will tend to pick the shortest period they can that gives them that full, protective response,” said Dr. Dean of the University of Florida.

But it’s unclear when that critical window really starts to close in the body. Akiko Iwasaki, an immunologist at Yale University who supports delaying second doses, said she thought the body’s memory of the first injection could last at least a few months.

Doses of other routine vaccines, she noted, are scheduled several months apart or even longer, to great success. “Let’s vaccinate as many people as possible now, and give them the booster dose when they become available,” she said.

Dr. Robert Wachter, an infectious disease physician at the University of California, San Francisco, said he was originally skeptical of the idea of delaying second doses.

But the disappointingly slow vaccine rollout in the United States, coupled with concerns about a new and fast-spreading variant of the coronavirus, have changed his mind, and he now believes this is a strategy worth exploring.

“The past couple weeks have been sobering,” he said.

Other researchers are less eager to take the gamble. Delaying doses without strong supporting data “is like going into the Wild West,” said Dr. Phyllis Tien, an infectious disease physician at the University of California, San Francisco. “I think we need to follow what the evidence says: two shots 21 days apart for Pfizer, or 28 days apart for Moderna.”

Some experts also fear that delaying an immunity-boosting second dose might give the coronavirus more opportunity to multiply and mutate in partly protected people.

There is some evidence to support the alternative strategy of halving the dose of each shot, suggested on Sunday by Mr. Slauoi of Operation Warp Speed.

In an interview on the CBS program “Face the Nation,” Dr. Slaoui pointed to data from clinical trials run by Moderna, whose vaccine is typically given in two doses, four weeks apart, each containing 100 micrograms of active ingredient.

In the trials, people between the ages of 18 and 55 who received two half-doses produced an “identical immune response to the 100 microgram dose,” Dr. Slaoui said. The F.D.A. and Moderna are now considering implementing this regimen on a more widespread scale, he added.

While there’s little or no data to support the soundness of delayed dose delays, Dr. Slaoui said, “injecting half the volume” might constitute “a more responsible approach that will be based on facts and data to immunize more people.”

But Dr. Dean and John Moore, a vaccine expert at Cornell University, both pointed out that this regimen would still represent a departure from the ones rigorously tested in clinical trials.

A half-dose that elicits an immune response that appears similar to that triggered by a full dose may not in the end deliver the expected protection against the coronavirus, Dr. Moore noted. Halving doses “is not something I would want to see done unless it were absolutely necessary,” he said.

“Everyone is looking for solutions right now, because there is an urgent need for more doses,” Dr. Dean said. “But the dust has not settled on the best way to achieve this.”